Preferred Label : R-CHOP Regimen;
NCIt synonyms : Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine; Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine; Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen; CTX/DOX/MOAB IDEC-C2B8/PRED/VCR; Rituximab Cyclophosphamide Doxorubicin Prednisone Vincristine; Rituxan/CHOP; CHOP-Rituximab;
NCIt related terms : R-CHOP;
CISMeF acronym : R-CHOP;
NCIt definition : A regimen consisting of cyclophosphamide, doxorubicin, prednisone, rituximab and vincristine
that may be used for the treatment of AIDS-related B-cell lymphomas, Castleman disease,
chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), diffuse large
B-cell lymphoma (DLBCL), follicular lymphoma, gastric and nongastric MALT lymphomas,
nodular lymphocyte-predominant Hodgkin lymphoma, mantle cell Lymphoma, nodal marginal
zone lymphoma (NMZL), splenic marginal zone lymphoma (SMZL), Waldenström macroglobulinemia
and lymphoplasmacytic lymphoma, and post-transplant lymphoproliferative disorders.;
Alternative definition : NCI-GLOSS: An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin
lymphoma and mantle cell lymphoma and is being studied in the treatment of other types
of cancer. It includes the drugs rituximab, cyclophosphamide, doxorubicin hydrochloride
(hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone.;
Codes from synonyms : CDR0000635897; CDR0000635896; 15921;
Origin ID : C9760;
UMLS CUI : C0393023;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
